UPDATE 1-Teva gains clearances for Barr deal, sets closing

NEW YORK, Dec 19 (Reuters) – Teva Pharmaceutical Industries
Ltd gained clearances on Friday from U.S. and European
antitrust regulators for its acquisition of rival generic
drugmaker Barr Pharmaceuticals Inc and set Dec. 23 as
the deal’s closing date.

Leave a Reply